These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 37495799)
1. Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients. van Haaren ERM; Poodt IGM; Spiekerman van Weezelenburg MA; van Bastelaar J; Janssen A; de Vries B; Lobbes MBI; Bouwman LH; Vissers YLJ Breast Cancer Res Treat; 2023 Nov; 202(2):245-255. PubMed ID: 37495799 [TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of sentinel lymph nodes in patients with breast cancer using one-step nucleic acid amplification (OSNA): Does not lead to overtreatment in the current era of de-escalating axillary management. Hintzen KFH; de Rooij L; Schouten N; van Bastelaar J; Cörvers SAJ; Janssen A; van Haaren ERM; Vissers YLJ Surg Oncol; 2020 Dec; 35():224-228. PubMed ID: 32932218 [TBL] [Abstract][Full Text] [Related]
3. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection. Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698 [TBL] [Abstract][Full Text] [Related]
4. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice. Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309 [TBL] [Abstract][Full Text] [Related]
5. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months. Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440 [TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer. Huxley N; Jones-Hughes T; Coelho H; Snowsill T; Cooper C; Meng Y; Hyde C; Mújica-Mota R Health Technol Assess; 2015 Jan; 19(2):v-xxv, 1-215. PubMed ID: 25586547 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer metastasis burden in sentinel nodes analysed using one-step nucleic acid amplification predicts axillary nodal status. Milner TD; de Lusignan S; Jones S; Jackson PA; Layer GT; Kissin MW; Irvine TE Breast; 2015 Oct; 24(5):568-75. PubMed ID: 26032111 [TBL] [Abstract][Full Text] [Related]
8. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making. Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008 [TBL] [Abstract][Full Text] [Related]
9. Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology. Osako T; Iwase T; Kimura K; Yamashita K; Horii R; Yanagisawa A; Akiyama F Cancer; 2011 Oct; 117(19):4365-74. PubMed ID: 21437889 [TBL] [Abstract][Full Text] [Related]
10. Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital. Banerjee SM; Michalopoulos NV; Williams NR; Davidson T; El Sheikh S; McDermott N; Tran-Dang MA; Davison S; Keshtgar MR Breast; 2014 Aug; 23(4):378-84. PubMed ID: 24630617 [TBL] [Abstract][Full Text] [Related]
11. Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA. Martín-Sánchez E; Pernaut-Leza E; Mendaza S; Cordoba A; Vicente-Garcia F; Monreal-Santesteban I; Vizcaino JP; De Cerio MJ; Perez-Janices N; Blanco-Luquin I; Escors D; Ulazia-Garmendia A; Guerrero-Setas D Virchows Arch; 2016 Jul; 469(1):51-9. PubMed ID: 27097811 [TBL] [Abstract][Full Text] [Related]
12. Two rare cases of endosalpingiosis in the axillary sentinel lymph nodes: evaluation of immunohistochemical staining and one-step nucleic acid amplification (OSNA) assay in patients with breast cancer. Shiino S; Yoshida M; Jimbo K; Asaga S; Takayama S; Maeshima A; Tsuda H; Kinoshita T; Hiraoka N Virchows Arch; 2019 May; 474(5):633-638. PubMed ID: 30756183 [TBL] [Abstract][Full Text] [Related]
13. Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients. Jimbo K; Kinoshita T; Ogura T; Watase C; Murata T; Shiino S; Takayama S; Yoshida M Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):516-521. PubMed ID: 31711717 [TBL] [Abstract][Full Text] [Related]
14. Is it Possible to Predict Non Sentinel Node Positivity on the Basis of mRNA Copy Numbers of CK19 Receptor in Breast Cancer? Sharma RD; Sharmin A; Sinha A; Solomon A; Huynh I; Alani A; Nagarajakumar A; Kasem A; Doddi S Clin Breast Cancer; 2021 Oct; 21(5):e561-e564. PubMed ID: 33712365 [TBL] [Abstract][Full Text] [Related]
15. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy. Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734 [TBL] [Abstract][Full Text] [Related]
16. Intra-operative use of one-step nucleic acid amplification (OSNA) for detection of the tumor load of sentinel lymph nodes in breast cancer patients. Heilmann T; Mathiak M; Hofmann J; Mundhenke C; van Mackelenbergh M; Alkatout I; Wenners A; Eckmann-Scholz C; Schem C J Cancer Res Clin Oncol; 2013 Oct; 139(10):1649-55. PubMed ID: 23907595 [TBL] [Abstract][Full Text] [Related]
17. The evolution of the sentinel node procedure in the treatment of breast cancer. Tvedskov TF Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889 [TBL] [Abstract][Full Text] [Related]
18. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance. Youssef MMG; Cameron D; Pucher PH; Olsen S; Ferguson D Breast; 2016 Dec; 30():101-104. PubMed ID: 27668857 [TBL] [Abstract][Full Text] [Related]
19. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand. Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675 [TBL] [Abstract][Full Text] [Related]
20. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis. Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]